Flash FinanceUS
Market open S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · BioRestorative Therapies, Inc. (BRTX)

BioRestorative Therapies to effect 1-for-20 reverse stock split effective September 7

Neutral Impact 3 of 5 shareholder Written later

BioRestorative Therapies filed a Nevada certificate of change for a 1-for-20 reverse stock split of its common stock, effective 4:30 p.m. Eastern on September 7, 2026, with the Board approving it on August 27, 2026 without stockholder approval. The company says the split is intended to regain compliance with the $1.00 minimum bid price requirement for continued listing on the Nasdaq Capital Market, and that each stockholder's ownership percentage will remain unchanged apart from fractional share rounding.

Key points

  • Every 20 shares of common stock will become one share; trading on a split-adjusted basis begins September 8, 2026 under BRTX with new CUSIP 090655705.
  • Shares outstanding will fall from 27,622,556 to approximately 1,381,128, and authorized common shares will drop from 1,500,000,000 to 75,000,000.
  • The split is intended to regain compliance with Nasdaq Listing Rule 5550(a)(2), the $1.00 minimum bid price requirement.

The filing

CompanyBioRestorative Therapies, Inc. (BRTX)
Form8-K, current report
Filed with the SECSep 2, 2026, 5:29 PM ET
Accession number0001213900-26-096810

Items reported: 3.03 Change to Shareholder Rights5.03 Bylaw / Charter Amendment7.01 Regulation FD Disclosure

Read the filing on SEC.gov ↗

Written by AI on Nov 9, 2026, 8:38 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on September 02, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.